DEDIFFERENTIATED CHONDROSARCOMA
Clinical trials for DEDIFFERENTIATED CHONDROSARCOMA explained in plain language.
Never miss a new study
Get alerted when new DEDIFFERENTIATED CHONDROSARCOMA trials appear
Sign up with your email to follow new studies for DEDIFFERENTIATED CHONDROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New daily pill could tame bone sarcomas
Disease control Recruiting nowThis phase 2 trial tests a daily oral drug called zanzalintinib in 70 adults with advanced or metastatic bone sarcomas that cannot be removed by surgery. The study includes four groups based on sarcoma type. Researchers will check if the drug is safe and helps control the cancer.
Matched conditions: DEDIFFERENTIATED CHONDROSARCOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Scientists hunt for better ways to diagnose and treat rare bone tumors
Knowledge-focused Recruiting nowThis study looks at 300 people with cartilage tumors, including both benign types and the cancer chondrosarcoma. Researchers are studying genetic changes and molecules called miRNAs to better tell these tumors apart and predict outcomes. The goal is to improve diagnosis and find …
Matched conditions: DEDIFFERENTIATED CHONDROSARCOMA
Sponsor: St. Anne's University Hospital Brno, Czech Republic • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC